Literature DB >> 10675899

Gene therapy: the first decade.

A Mountain1.   

Abstract

Gene therapy promises to revolutionize medicine by treating the causes of disease rather than the symptoms. We are nearing the end of the first decade of gene therapy, and this article summarizes the approaches taken, results achieved, lessons learned and important recent developments. The early results on the clinical efficacy of gene therapies were disappointing, largely because the available gene-transfer vectors proved to be inadequate. Recently, however, clinical benefit has been clearly demonstrated and great progress made in selecting and improving vectors. There is now every prospect that the second decade will see gene therapy live up to its enormous potential.

Mesh:

Year:  2000        PMID: 10675899     DOI: 10.1016/s0167-7799(99)01416-x

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  38 in total

1.  Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.

Authors:  C J Kuo; F Farnebo; E Y Yu; R Christofferson; R A Swearingen; R Carter; H A von Recum; J Yuan; J Kamihara; E Flynn; R D'Amato; J Folkman; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis.

Authors:  Young Jik Kwon; Gene Hung; W French Anderson; Ching-An Peng; Hong Yu
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Gene therapy in epilepsy.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

4.  Transfection mediated by pH-sensitive sugar-based gemini surfactants; potential for in vivo gene therapy applications.

Authors:  Luc Wasungu; Marco Scarzello; Gooitzen van Dam; Grietje Molema; Anno Wagenaar; Jan B F N Engberts; Dick Hoekstra
Journal:  J Mol Med (Berl)       Date:  2006-06-08       Impact factor: 4.599

5.  Analysis of the expression of coxsackievirus and adenovirus receptor in five colon cancer cell lines.

Authors:  Yassan Abdolazimi; Majid Mojarrad; Mehrdad Pedram; Mohammad Hossein Modarressi
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

6.  Novel therapeutic strategies for epilepsy--releasing the gene Genie.

Authors:  Graeme J Sills
Journal:  Epilepsy Curr       Date:  2009 Jan-Feb       Impact factor: 7.500

7.  Gene therapy, early promises, subsequent problems, and recent breakthroughs.

Authors:  Saeideh Razi Soofiyani; Behzad Baradaran; Farzaneh Lotfipour; Tohid Kazemi; Leila Mohammadnejad
Journal:  Adv Pharm Bull       Date:  2013-08-20

8.  Visualization of targeted transduction by engineered lentiviral vectors.

Authors:  K-I Joo; P Wang
Journal:  Gene Ther       Date:  2008-05-15       Impact factor: 5.250

9.  Hydrophobic oxime ethers: a versatile class of pDNA and siRNA transfection lipids.

Authors:  Souvik Biswas; Ralph J Knipp; Laura E Gordon; Seshagiri R Nandula; Sven-Ulrik Gorr; Geoffrey J Clark; Michael H Nantz
Journal:  ChemMedChem       Date:  2011-08-31       Impact factor: 3.466

10.  Gene delivery via DNA incorporation within a biomimetic apatite coating.

Authors:  Linh N Luong; Kristen M McFalls; David H Kohn
Journal:  Biomaterials       Date:  2009-09-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.